World's Best Scientists 2026 revealed!
Peter E. Schwartz

Peter E. Schwartz

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 87 13712 12902 6962 6438 541 26043

Peter E. Schwartz publications per year

The chart shows the history of publications by Peter E. Schwartz between 1967 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Peter E. Schwartz published across 59 years, from 1967 to 2025, averaging 11.2 papers a year. Output peaked at 86 publications in 2023. 20 of the 661 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1967 to 2025. Vertical axis: number of publications, 0 to 86. Peak 86 publications in 2023. 1967: 1 publication 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 2 publications 1976: 0 publications 1977: 0 publications 1978: 1 publication 1979: 3 publications 1980: 7 publications 1981: 7 publications 1982: 9 publications 1983: 11 publications 1984: 1 publication 1985: 9 publications 1986: 8 publications 1987: 11 publications 1988: 13 publications 1989: 19 publications 1990: 10 publications 1991: 15 publications 1992: 8 publications 1993: 12 publications 1994: 8 publications 1995: 10 publications 1996: 12 publications 1997: 4 publications 1998: 4 publications 1999: 5 publications 2000: 2 publications 2001: 9 publications 2002: 4 publications 2003: 13 publications 2004: 11 publications 2005: 12 publications 2006: 9 publications 2007: 6 publications 2008: 16 publications 2009: 16 publications 2010: 26 publications 2011: 33 publications 2012: 27 publications 2013: 17 publications 2014: 17 publications 2015: 33 publications 2016: 12 publications 2017: 15 publications 2018: 20 publications 2019: 23 publications 2020: 13 publications 2021: 18 publications 2022: 13 publications 2023: 86 publications 2024: 18 publications 2025: 2 publications
1967 2025

661 publications in total across all disciplines

View publications per year as a table
Peter E. Schwartz: publications per year, 1967 to 2025
Year Publications
1967 1
1968 0
1969 0
1970 0
1971 0
1972 0
1973 0
1974 0
1975 2
1976 0
1977 0
1978 1
1979 3
1980 7
1981 7
1982 9
1983 11
1984 1
1985 9
1986 8
1987 11
1988 13
1989 19
1990 10
1991 15
1992 8
1993 12
1994 8
1995 10
1996 12
1997 4
1998 4
1999 5
2000 2
2001 9
2002 4
2003 13
2004 11
2005 12
2006 9
2007 6
2008 16
2009 16
2010 26
2011 33
2012 27
2013 17
2014 17
2015 33
2016 12
2017 15
2018 20
2019 23
2020 13
2021 18
2022 13
2023 86
2024 18
2025 2
Total 661
Download as CSV

Peter E. Schwartz publications per year - data summary

  • Peter E. Schwartz, a Medicine scholar from Yale University, has 661 publications recorded across 59 years, from 1967 to 2025.
  • The oldest publication on record dates to 1967 and the most recent to 2025.
  • The most productive year is 2023, with 86 publications.
  • The least productive years with any output are 1967, 1978 and 1984, with 1 publication each.
  • 9 of the 59 years in the span carry no publications at all (1968, 1969, 1970, 1971 and others).
  • The rate of publication averages 11.2 papers per year over the whole span, or 13.2 per year counting only the 50 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 137 publications, 21% of the career total.
  • Split into equal eras - 1967-1986: 59 publications (3.0 per year); 1987-2006: 191 publications (9.6 per year); 2007-2025: 411 publications (21.6 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Peter E. Schwartz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter E. Schwartz sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 541–560 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 541 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537 541
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Peter E. Schwartz publication distribution in Medicine in 2026 - data summary

  • The chart plots the publication count of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 86 ranges running from 101–120 to 1,796+ publications.
  • Peter E. Schwartz, a Medicine scholar from Yale University, records 541 publications - the 64th percentile of the discipline.
  • 64% of ranked Medicine scientists score the same or lower than Peter E. Schwartz, and about 36% score higher.
  • The median of the discipline falls in the 441–460 publications range, and Peter E. Schwartz ranks above the median.
  • The most crowded range is 341–360 publications, holding 922 scientists (5% of the field).
  • 64% of the field sits in the lowest quarter of the value range (up to 521–540 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,796 publications or more, 100 scientists in all (<1% of the field).

Peter E. Schwartz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter E. Schwartz sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960 87
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Peter E. Schwartz D-index placement in Medicine in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 75 ranges running from 70–71 to 217+ D-Index.
  • Peter E. Schwartz, a Medicine scholar from Yale University, records 87 D-Index - the 34th percentile of the discipline.
  • 34% of ranked Medicine scientists score the same or lower than Peter E. Schwartz, and about 66% score higher.
  • The median of the discipline falls in the 94–95 D-Index range, and Peter E. Schwartz ranks below the median.
  • The most crowded range is 82–83 D-Index, holding 1,027 scientists (5% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 106–107 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 217 D-Index or more, 98 scientists in all (<1% of the field).

Overview

Peter E. Schwartz is affiliated with Yale University in the United States. Their research is primarily situated in the field of Medicine, with a significant focus on Oncology and related subfields such as Reproductive Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, and Cancer Research.

The scientist's research topics cover a range of subjects concentrated on cancer diagnosis and treatment, including:

  • Ovarian cancer diagnosis and treatment
  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Sarcoma Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Intraperitoneal and Appendiceal Malignancies
  • Cell Adhesion Molecules Research

Recent papers authored or co-authored by Peter E. Schwartz include:

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis, 2020, Clinical Cancer Research
  • Integrated mutational landscape analysis of uterine leiomyosarcomas, 2021, Proceedings of the National Academy of Sciences
  • A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability, 2021, Cancer
  • Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan, 2020, Scientific Reports
  • Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer, 2020, Frontiers in Oncology

Frequent co-authors collaborating with Peter E. Schwartz include:

  • Elena Ratner
  • Alessandro D. Santin
  • Masoud Azodi
  • Gary Altwerger
  • Stefania Bellone

The scientist's work appears in a variety of publication venues, with multiple publications in:

  • Gynecologic Oncology
  • Clinical Cancer Research
  • Proceedings of the National Academy of Sciences
  • Journal of Clinical Oncology
  • British Journal of Cancer

Best Publications

  • Serum protein markers for early detection of ovarian cancer

    Gil Mor;Irene Visintin;Yinglei Lai;Hongyu Zhao

  • Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

    Ayesha B. Alvero;Rui Chen;Han-Hsuan Fu;Michele Montagna

  • Diagnostic Markers for Early Detection of Ovarian Cancer

    Irene Visintin;Ziding Feng;Gary Longton;David C. Ward

  • High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

    Urania Magriples;Frederick Naftolin;Peter E. Schwartz;Maria Luisa Carcangiu

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

    Amanda N. Fader;Dana M. Roque;Eric Siegel;Natalia Buza

  • BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

    Roxana Moslehi;Roxana Moslehi;William Chu;Beth Karlan;David Fishman

  • Psychosocial benefits of a cancer support group.

    Eileen N. Cain;Ernest I. Kohorn;Donald M. Quinlan;Kate Latimer

  • Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells

    R Chen;A B Alvero;D A Silasi;M G Kelly

  • A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM

    Jennwer L. Kelsey;Virginia A. Livolsi;Theodore R Holford;Diana B. Fischer

  • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.

    B E Nelson;A T Rosenfield;P E Schwartz

  • AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY

    Nancy G. Hildreth;Jennifer L. Kelsey;Virginia A. Livolsi;Diana B. Fischer

  • Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

    Siming Zhao;Murim Choi;John D. Overton;Stefania Bellone

  • Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci

    Mary Carrington;Sophia Wang;Maureen P. Martin;Xiaojiang Gao

  • Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.

    Jacob Tangir;Daniel Zelterman;Wenging Ma;Peter E Schwartz

  • Low-grade endometrial stromal sarcoma: hormonal aspects☆

    Micheline C Chu;Gil Mor;Chungyun Lim;Wenxin Zheng

  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

    Antonis C. Antoniou;Jonathan Beesley;Lesley McGuffog;Olga M. Sinilnikova

  • Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.

    June Y. Hou;Michael G. Kelly;Herbert Yu;Jessica N. McAlpine

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

    Amanda N. Fader;Dana M. Roque;Eric Siegel;Natalia Buza

  • The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

    Wenxin Zheng;Xiaofang Yi;Oluwole Fadare;Oluwole Fadare;Sharon X. Liang

  • Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

    Michael G. Kelly;David M. O'malley;Pei Hui;Jessica Mcalpine

Frequent Co-Authors

Alessandro D. Santin
Alessandro D. Santin Yale University
Sergio Pecorelli
Sergio Pecorelli University of Brescia
Gil Mor
Gil Mor Wayne State University
Lingeng Lu
Lingeng Lu Yale University
Neil J. MacLusky
Neil J. MacLusky University of Guelph
Cary P. Gross
Cary P. Gross Yale University
Melinda L. Irwin
Melinda L. Irwin Yale University
Harvey A. Risch
Harvey A. Risch Yale University
Jason D. Wright
Jason D. Wright Columbia University
Virginia A. LiVolsi
Virginia A. LiVolsi University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open up rewarding career opportunities for those interested in medicine, but looking for flexible or accessible online routes. For students who want to enter the field quickly, there are easy nursing programs to get into that offer a streamlined admission process, helping aspiring nurses start their education without lengthy waiting periods.

Some students may be concerned about standardized testing. Fortunately, there are nursing school that don't require teas or other entrance exams, making the application process more accessible.

If you’re interested in administration or working behind the scenes, earning a health administration degree online may be the right choice. These programs prepare students for management roles in hospitals, clinics, and other healthcare settings.

For those drawn to healthcare but not direct patient care, consider exploring medical billing and coding schools online. This field is vital for the smooth operation of healthcare facilities and offers strong career prospects—all from a remote or flexible learning environment.

Best Scientists Citing Peter E. Schwartz

Trending Scientists

Recently Published Articles